Clinical Drug Experience Knowledgebase

Prostatic Neoplasms

Prostatic Neoplasms, Castration-Resistant

Adenocarcinoma (Phase 3)

Alzheimer Disease (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Endometrioid (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 1)

Colorectal Neoplasms (Phase 2)

Endometrial Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Hepatic Insufficiency (Phase 1)

Huntington Disease (Phase 3)

Hypersensitivity (Phase 3)

Kidney Diseases (Phase 1)

Leukemia (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Liver Diseases (Phase 1)

Liver Failure (Phase 1)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 1)

Melanoma (Phase 2)

Myelodysplastic Syndromes (Phase 1)

Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 1)

Prostatic Neoplasms (Phase 4)

Sarcoma, Ewing (Phase 1)

Seizures (Phase 4)

Small Cell Lung Carcinoma (Phase 1)

Triple Negative Breast Neoplasms (Phase 3)